Physicians' approaches to post-abortion care in Manila, Philippines

Catherine Cansino, Junice Lirza Melgar, Anne Burke

Research output: Contribution to journalArticle

Abstract

Objective: To assess the knowledge and practice of health professionals in Manila, Philippines, regarding methods used for uterine evacuation in post-abortion care (PAC), including the use of misoprostol. Methods: A purposive sample of physicians providing PAC services completed questionnaires anonymously about PAC practices. Results: Among 45 survey respondents, the primary methods used for first-trimester uterine evacuation in PAC included sharp curettage (n = 45, 100%) and manual vacuum aspiration (MVA; n = 38, 84.4%), which was consistent with their preferences. Misoprostol was prescribed for first-trimester post-abortion uterine evacuation by 55.6% (n = 25) of respondents; dosing regimens ranged from 50 to 200 μg as a single dose or repeated every 4-24 hours. Of the respondents, 91.1% (n = 41) prescribed misoprostol for obstetric indications, including labor induction and postpartum hemorrhage. Conclusions: Most respondents used sharp curettage and MVA for first-trimester post-abortion uterine evacuation, and did not express a clear preference for either method. Despite the unregistered status of misoprostol, it was used in obstetrics and PAC by a majority of study respondents. The doses of misoprostol used for post-abortion uterine evacuation are lower than those recommended by evidence-based studies. The results indicate the need to disseminate evidence-based information about safe and effective use of MVA and misoprostol for PAC to physicians in Manila, Philippines.

Original languageEnglish (US)
Pages (from-to)216-218
Number of pages3
JournalInternational Journal of Gynecology and Obstetrics
Volume109
Issue number3
DOIs
StatePublished - Jun 2010

Fingerprint

Philippines
Misoprostol
Physicians
First Pregnancy Trimester
Curettage
Obstetrics
Induced Labor
Postpartum Hemorrhage
Professional Practice
Vacuum
Surveys and Questionnaires
Health

Keywords

  • Induced abortion
  • Manual vacuum aspiration
  • Misoprostol
  • Philippines
  • Post-abortion care
  • Sharp curettage

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Physicians' approaches to post-abortion care in Manila, Philippines. / Cansino, Catherine; Melgar, Junice Lirza; Burke, Anne.

In: International Journal of Gynecology and Obstetrics, Vol. 109, No. 3, 06.2010, p. 216-218.

Research output: Contribution to journalArticle

Cansino, Catherine ; Melgar, Junice Lirza ; Burke, Anne. / Physicians' approaches to post-abortion care in Manila, Philippines. In: International Journal of Gynecology and Obstetrics. 2010 ; Vol. 109, No. 3. pp. 216-218.
@article{550dd89b426c43b1b5929d23c252f41b,
title = "Physicians' approaches to post-abortion care in Manila, Philippines",
abstract = "Objective: To assess the knowledge and practice of health professionals in Manila, Philippines, regarding methods used for uterine evacuation in post-abortion care (PAC), including the use of misoprostol. Methods: A purposive sample of physicians providing PAC services completed questionnaires anonymously about PAC practices. Results: Among 45 survey respondents, the primary methods used for first-trimester uterine evacuation in PAC included sharp curettage (n = 45, 100{\%}) and manual vacuum aspiration (MVA; n = 38, 84.4{\%}), which was consistent with their preferences. Misoprostol was prescribed for first-trimester post-abortion uterine evacuation by 55.6{\%} (n = 25) of respondents; dosing regimens ranged from 50 to 200 μg as a single dose or repeated every 4-24 hours. Of the respondents, 91.1{\%} (n = 41) prescribed misoprostol for obstetric indications, including labor induction and postpartum hemorrhage. Conclusions: Most respondents used sharp curettage and MVA for first-trimester post-abortion uterine evacuation, and did not express a clear preference for either method. Despite the unregistered status of misoprostol, it was used in obstetrics and PAC by a majority of study respondents. The doses of misoprostol used for post-abortion uterine evacuation are lower than those recommended by evidence-based studies. The results indicate the need to disseminate evidence-based information about safe and effective use of MVA and misoprostol for PAC to physicians in Manila, Philippines.",
keywords = "Induced abortion, Manual vacuum aspiration, Misoprostol, Philippines, Post-abortion care, Sharp curettage",
author = "Catherine Cansino and Melgar, {Junice Lirza} and Anne Burke",
year = "2010",
month = "6",
doi = "10.1016/j.ijgo.2010.01.005",
language = "English (US)",
volume = "109",
pages = "216--218",
journal = "International Journal of Gynecology and Obstetrics",
issn = "0020-7292",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Physicians' approaches to post-abortion care in Manila, Philippines

AU - Cansino, Catherine

AU - Melgar, Junice Lirza

AU - Burke, Anne

PY - 2010/6

Y1 - 2010/6

N2 - Objective: To assess the knowledge and practice of health professionals in Manila, Philippines, regarding methods used for uterine evacuation in post-abortion care (PAC), including the use of misoprostol. Methods: A purposive sample of physicians providing PAC services completed questionnaires anonymously about PAC practices. Results: Among 45 survey respondents, the primary methods used for first-trimester uterine evacuation in PAC included sharp curettage (n = 45, 100%) and manual vacuum aspiration (MVA; n = 38, 84.4%), which was consistent with their preferences. Misoprostol was prescribed for first-trimester post-abortion uterine evacuation by 55.6% (n = 25) of respondents; dosing regimens ranged from 50 to 200 μg as a single dose or repeated every 4-24 hours. Of the respondents, 91.1% (n = 41) prescribed misoprostol for obstetric indications, including labor induction and postpartum hemorrhage. Conclusions: Most respondents used sharp curettage and MVA for first-trimester post-abortion uterine evacuation, and did not express a clear preference for either method. Despite the unregistered status of misoprostol, it was used in obstetrics and PAC by a majority of study respondents. The doses of misoprostol used for post-abortion uterine evacuation are lower than those recommended by evidence-based studies. The results indicate the need to disseminate evidence-based information about safe and effective use of MVA and misoprostol for PAC to physicians in Manila, Philippines.

AB - Objective: To assess the knowledge and practice of health professionals in Manila, Philippines, regarding methods used for uterine evacuation in post-abortion care (PAC), including the use of misoprostol. Methods: A purposive sample of physicians providing PAC services completed questionnaires anonymously about PAC practices. Results: Among 45 survey respondents, the primary methods used for first-trimester uterine evacuation in PAC included sharp curettage (n = 45, 100%) and manual vacuum aspiration (MVA; n = 38, 84.4%), which was consistent with their preferences. Misoprostol was prescribed for first-trimester post-abortion uterine evacuation by 55.6% (n = 25) of respondents; dosing regimens ranged from 50 to 200 μg as a single dose or repeated every 4-24 hours. Of the respondents, 91.1% (n = 41) prescribed misoprostol for obstetric indications, including labor induction and postpartum hemorrhage. Conclusions: Most respondents used sharp curettage and MVA for first-trimester post-abortion uterine evacuation, and did not express a clear preference for either method. Despite the unregistered status of misoprostol, it was used in obstetrics and PAC by a majority of study respondents. The doses of misoprostol used for post-abortion uterine evacuation are lower than those recommended by evidence-based studies. The results indicate the need to disseminate evidence-based information about safe and effective use of MVA and misoprostol for PAC to physicians in Manila, Philippines.

KW - Induced abortion

KW - Manual vacuum aspiration

KW - Misoprostol

KW - Philippines

KW - Post-abortion care

KW - Sharp curettage

UR - http://www.scopus.com/inward/record.url?scp=77951649209&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951649209&partnerID=8YFLogxK

U2 - 10.1016/j.ijgo.2010.01.005

DO - 10.1016/j.ijgo.2010.01.005

M3 - Article

VL - 109

SP - 216

EP - 218

JO - International Journal of Gynecology and Obstetrics

JF - International Journal of Gynecology and Obstetrics

SN - 0020-7292

IS - 3

ER -